abiraterone has been researched along with 4-hydroxy-n-desmethyltamoxifen in 1 studies
Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (4-hydroxy-n-desmethyltamoxifen) | Trials (4-hydroxy-n-desmethyltamoxifen) | Recent Studies (post-2010) (4-hydroxy-n-desmethyltamoxifen) |
---|---|---|---|---|---|
942 | 97 | 854 | 215 | 18 | 183 |
Protein | Taxonomy | abiraterone (IC50) | 4-hydroxy-n-desmethyltamoxifen (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.03 | |
Aromatase | Homo sapiens (human) | 6.0333 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; de Jong, KAM; de Vries, N; Rosing, H; van Nuland, M; Venekamp, N | 1 |
1 other study(ies) available for abiraterone and 4-hydroxy-n-desmethyltamoxifen
Article | Year |
---|---|
Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology.
Topics: Administration, Oral; Anastrozole; Androstadienes; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Benzamides; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Nitriles; Phenylthiohydantoin; Tamoxifen; Tandem Mass Spectrometry; Tosyl Compounds | 2019 |